Organization | William Beaumont Hospitals

William Beaumont Hospitals Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial

2011

NCT01325779

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Beaumont Hospital | Jason Gilleran | Lisa Louwers

Active Ingredients

Drugs in Phase 2 Trials (7)

cold blood (1 trial)

gemcitabine (gemzar) (1 trial)

ketoglutarate (1 trial)

l-histidine (1 trial)

paclitaxel (taxol) (1 trial)

paricalcitol (zemplar) (1 trial)

tryptophan (1 trial)

Drugs in Phase 1 Trials (1)

diazepam (valium) (1 trial)

Drugs in Other Trials (2)

enoxaparin (lovenox) (1 trial)

heparin (liquaemin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Heart Diseases (Phase 2)

Heart Valve Diseases (Phase 2)

Ischemia (Phase 2)

Myocardial Ischemia (Phase 2)

Pancreatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 4
# of Trial APIs: 10